# Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial

> **NCT05320926** · NA · RECRUITING · sponsor: **Yonsei University** · enrollment: 3744 (estimated)

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DRUG:** Clopidogrel monotherapy
- **DRUG:** Aspirin monotherapy
- **DEVICE:** zotarolimus-eluting stent (Resolute Onyx ®)

## Key facts

- **NCT ID:** NCT05320926
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-26
- **Primary completion:** 2028-07-10
- **Final completion:** 2028-07-10
- **Target enrollment:** 3744 (ESTIMATED)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05320926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05320926, "Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05320926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*